Kevin C. Tang is a businessperson who founded Ardea Biosciences, Inc. and Tang Capital Management LLC and who has been at the helm of 6 different companies. Mr. Tang occupies the position of Chairman at La Jolla Pharmaceutical Co., Chairman & Chief Executive Officer of Odonate Therapeutics, Inc. and President of Tang Capital Management LLC. Kevin C. Tang is also on the board of Tetraphase Pharmaceuticals, Inc. and Prospect Therapeutics, Inc.

In his past career he was Chairman of Heron Therapeutics, Inc., Director at Penwest Pharmaceuticals Co., Managing Director & Head-Life Sciences Research at Deutsche Bank Alex. Brown, Inc., Head of Life Sciences Research Group at Deutsche Bank Securities, Inc., Managing Director at Cash Reserve Fund, Inc., Director at IntraBiotics Pharmaceuticals, Inc. and Independent Director at Ardea Biosciences, Inc.

He received an undergraduate degree from Duke University.